470 related articles for article (PubMed ID: 24018020)
21. Neoadjuvant chemotherapy for bladder cancer.
Sonpavde G; Lerner SP
Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials.
Advanced Bladder Cancer (ABC) Meta-analysis Collaborators Group
Eur Urol; 2022 Jan; 81(1):50-61. PubMed ID: 34802798
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
24. Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder.
Sternberg CN; Pansadoro V; Calabro F; Marini L; van Rijn A; Carli PD; Giannarelli D; Platania A; Rossetti A
Ann Oncol; 1999 Nov; 10(11):1301-5. PubMed ID: 10631456
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder.
Raghavan D
Urol Oncol; 2003; 21(6):468-74. PubMed ID: 14693275
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.
Logothetis CJ; Johnson DE; Chong C; Dexeus FH; Sella A; Ogden S; Smith T; Swanson DA; Babaian RJ; Wishnow KI
J Clin Oncol; 1988 Oct; 6(10):1590-6. PubMed ID: 3171626
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA
Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155
[TBL] [Abstract][Full Text] [Related]
28. [Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer].
Stöckle M
Urologe A; 1994 Nov; 33(6):568-75. PubMed ID: 7817458
[TBL] [Abstract][Full Text] [Related]
29. A systematic overview of chemotherapy effects in urothelial bladder cancer.
Nilsson S; Ragnhammar P; Glimelius B; Nygren P;
Acta Oncol; 2001; 40(2-3):371-90. PubMed ID: 11441942
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
[TBL] [Abstract][Full Text] [Related]
31. RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
Hagan MP; Winter KA; Kaufman DS; Wajsman Z; Zietman AL; Heney NM; Toonkel LM; Jones CU; Roberts JD; Shipley WU
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):665-72. PubMed ID: 14529770
[TBL] [Abstract][Full Text] [Related]
32. Radiation, chemotherapy and transurethral surgery: an organ-sparing alternative to the radical cystectomy.
Zietman AL
Front Radiat Ther Oncol; 2002; 36():131-46. PubMed ID: 11842743
[No Abstract] [Full Text] [Related]
33. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
Leow JJ; Chong YL; Chang SL; Valderrama BP; Powles T; Bellmunt J
Eur Urol; 2021 May; 79(5):635-654. PubMed ID: 32798146
[TBL] [Abstract][Full Text] [Related]
34. Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209.
Kitamura H; Tsukamoto T; Shibata T; Masumori N; Fujimoto H; Hirao Y; Fujimoto K; Kitamura Y; Tomita Y; Tobisu K; Niwakawa M; Naito S; Eto M; Kakehi Y;
Ann Oncol; 2014 Jun; 25(6):1192-8. PubMed ID: 24669010
[TBL] [Abstract][Full Text] [Related]
35. Nordic prospective trials of radical cystectomy and neoadjuvant chemotherapy. The Nordic Cooperative Bladder Cancer Study Group.
Hellsten S; Rintala E; Wahlqvist R; Malmström PU
Eur Urol; 1998; 33 Suppl 4():35-8. PubMed ID: 9615209
[No Abstract] [Full Text] [Related]
36. Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival.
Russell B; Sherif A; Häggström C; Josephs D; Kumar P; Malmström PU; Van Hemelrijck M
Scand J Urol; 2019 Aug; 53(4):206-212. PubMed ID: 31174452
[No Abstract] [Full Text] [Related]
37. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.
Izawa JI; Chin JL; Winquist E
Can J Urol; 2006 Jun; 13 Suppl 3():48-53. PubMed ID: 16818012
[TBL] [Abstract][Full Text] [Related]
38. Perioperative chemotherapy for muscle invasive bladder cancer.
Rudzinski JK; Basappa NS; North S
Curr Opin Support Palliat Care; 2015 Sep; 9(3):249-54. PubMed ID: 26125306
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
[TBL] [Abstract][Full Text] [Related]
40. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]